PTC Therapeutics' gene therapy is already approved in the European ... alongside the dollar on Thursday as investors bet that ...

Improvements to premium tax credits, enacted in the American Rescue Plan and extended by the Inflation Reduction Act, have ...

PTC Therapeutics (PTCT) announced that the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever ...

An enhanced premium tax credit for Marketplace plans will expire at 2025-end. If Congress doesn't act soon, millions may go ...

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth quarter conference call. During this presen ...

PTC (NASDAQ:PTC) is preparing to release its quarterly earnings on Wednesday, 2024-11-06. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect PTC ...

Learn how the government affects taxes, trade, markets, interest rates, and more through policy, regulation, and legislation. The most common way governments control inflation is by raising or ...

PTC (PTC) announced that its Board of Directors has authorized the repurchase of up to $2B worth of PTC common stock through September 30, 2027. The views and opinions expressed herein are the ...

Constellation Energy Corporation stock has been volatile due to regulatory concerns, but power demand is growing. Click here ...

In the latest quarter, 6 analysts provided ratings for PTC PTC, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts ...

In a report released on November 8, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a ...

Analysts expect PTC to report an earnings per share (EPS) of $1.45. PTC bulls will hope to hear the company announce they've ...